アジア太平洋地域の眼科市場 - 業界動向と2032年までの予測

Customize Your Report レポートをカスタマイズする Buy Now 今すぐ購入 Free Sample Report 無料サンプルレポート
Home Medical Devices Asia Pacific Ophthalmology Market
Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Free Sample Report 無料サンプルレポート Inquire Before Buying 事前に問い合わせる Buy Now今すぐ購入

アジア太平洋地域の眼科市場 - 業界動向と2032年までの予測

  • Medical Devices
  • Published Report
  • Nov 2024
  • Asia-Pacific
  • 350 ページ
  • テーブル数: 478
  • 図の数: 38
Buy Now 今すぐ購入 Request for Sample 無料サンプルPDFをダウンロード
Nucleus Nucleus

アジャイルなサプライチェーンコンサルティングで関税の課題を回避

サプライチェーンエコシステム分析は、現在DBMRレポートの一部です

アジア太平洋地域の眼科市場

Market Size in USD Billion

CAGR :  % Diagram

Chart Image USD 15.84 Billion USD 28.23 Billion 2024 2032
Diagram 予測期間
 2025 –2032
Diagram 市場規模（基準年）
 USD 15.84 Billion
Diagram Market Size (Forecast Year)
 USD 28.23 Billion
Diagram CAGR
 %
Diagram 主要市場プレーヤー
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

アジア太平洋地域の眼科市場セグメンテーション、製品別（デバイス、医薬品、その他）、疾患別（白内障、屈折異常、緑内障、加齢黄斑変性、炎症性疾患、その他）、総合眼科検査（屈折検査、視力検査、眼圧検査、前眼部および瞳孔検査、視野検査、色覚検査、その他）、エンドユーザー別（クリニック、病院、在宅医療、その他）、流通チャネル別（小売販売、直接入札、その他） - 2032年までの業界動向と予測

アジア太平洋地域の眼科市場

アジア太平洋地域の眼科市場分析

アジア太平洋地域の眼科市場は、エジプトとギリシャにおける古代の眼疾患治療法に始まり、数世紀にわたり大きく発展してきました。この分野は、より高度な外科手術技術と器具の開発に伴い、17世紀と18世紀に形成され始めました。19世紀には、検眼鏡などの革新が診断能力を変革しました。20世紀には、白内障手術や眼内レンズの発明といった画期的な進歩があり、1990年代にはレーシック手術が導入されました。21世紀は、人口の高齢化、技術の進歩、そして光干渉断層撮影（OCT）や網膜画像システムといった特殊な診断・手術機器の開発に牽引され、継続的な成長を遂げました。近年のトレンドは、人工知能、遠隔医療、そして遺伝子治療や幹細胞治療といった生物学的療法の利用拡大に焦点を当てており、市場の成長をさらに促進しています。今日、眼科市場は、眼疾患の罹患率の上昇、新しい技術、治療オプションの進化により拡大し続けています。

アジア太平洋地域の眼科市場規模

アジア太平洋地域の眼科市場は、2025年から2032年の予測期間に7.5%のCAGRで成長し、2024年の158億4,000万米ドルから2032年には282億3,000万米ドルに達すると予想されています。

データブリッジマーケットリサーチがまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、輸出入分析、生産能力概要、生産消費分析、価格動向分析、気候変動シナリオ、サプライチェーン分析、バリューチェーン分析、原材料/消耗品概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制枠組みも含まれています。

 アジア太平洋地域の眼科市場動向

「生理食塩水プレフィルドシリンジの安全性と効率性の向上」

アジア太平洋地域の眼科市場は、眼疾患の増加、技術の進歩、そして人口の高齢化を背景に、堅調な成長を遂げています。白内障、緑内障、糖尿病網膜症、加齢黄斑変性症などの疾患の増加は、眼科治療の需要増加に寄与しています。特にアジア太平洋地域の人口高齢化は、高齢者が視力関連の問題を抱えやすいことから、この傾向に大きく影響しています。さらに、光干渉断層撮影（OCT）、眼底カメラ、AI搭載システムといった診断技術の進歩により、診断の精度と効率が向上しています。レーザー治療やロボット支援手術といった低侵襲手術技術の人気が高まり、回復期間の短縮と患者の転帰改善が期待されています。さらに、網膜疾患などの疾患に対する標的治療を含む、眼科における個別化医療の発展も重要な役割を果たしています。注射用生物製剤や徐放性インプラントといった新たな薬剤送達システムの導入は、特に慢性疾患の治療効果を向上させています。遠隔診療やバーチャルスクリーニングの普及に伴い、眼科市場における遠隔医療も成長トレンドとなっており、医療サービスが行き届いていない地域における医療へのアクセス向上につながっています。主要市場プレーヤーは製品ポートフォリオの拡充を目指して研究開発に注力する一方、新興市場では手頃な価格で利用しやすい眼科ソリューションへの需要が高まっています。イノベーション、患者ケアの向上、医療アクセスの拡大に重点を置くことで、眼科市場は今後数年間で大幅な成長が見込まれます。

レポートの範囲とアジア太平洋眼科市場のセグメンテーション          

属性

アジア太平洋地域の眼科市場に関する洞察

対象セグメント

製品別：デバイス、医薬品、その他

疾患別：白内障、屈折異常、緑内障、加齢黄斑変性、炎症性疾患など

総合的な 眼科 検査：屈折検査、視力検査、眼圧検査、前眼部・瞳孔検査、視野検査、色覚検査など

エンドユーザー別：診療所、病院、在宅医療、その他

流通 チャネル別：小売販売、直接入札、その他

対象地域

中国、インド、日本、韓国、オーストラリア、インドネシア、タイ、マレーシア、フィリピン、シンガポール、その他のアジア太平洋地域

主要な市場プレーヤー

アルコン（スイス）、ボシュロム（カナダ）、カールツァイスメディテック（ドイツ）、HOYA株式会社（日本）、ジョンソン・エンド・ジョンソン・サービス株式会社（米国）、エシロールインターナショナル（フランス）、株式会社トプコン（日本）、グラウコス株式会社（米国）、ハーグ・シュトライトグループ（スイス）、ニデック株式会社（米国）、スタールサージカル（カリフォルニア州）、ジーマー・オフタルミック・システムズ株式会社（スイス）、クーパー・カンパニーズ株式会社（米国）、ルミナス・ビー株式会社（イスラエル）、ライヒェルト株式会社（ニューヨーク）、バイエル株式会社（ドイツ）、ノバルティス株式会社（スイス）、アッヴィ株式会社（米国）、F.ホフマン・ラ・ロシュ株式会社（スイス）、ドンペ株式会社（イタリア）、参天製薬株式会社（日本）他

市場機会
  • 高齢化人口の増加
  • オンライン小売とeヘルスプラットフォームの台頭
  • 患者教育の強化

付加価値データ情報セット

データブリッジマーケットリサーチがまとめた市場レポートには、市場価値、成長率、セグメンテーション、地理的範囲、主要プレーヤーなどの市場シナリオに関する洞察に加えて、輸出入分析、生産能力概要、生産消費分析、価格動向分析、気候変動シナリオ、サプライチェーン分析、バリューチェーン分析、原材料/消耗品概要、ベンダー選択基準、PESTLE分析、ポーター分析、規制枠組みも含まれています。

アジア太平洋地域の眼科市場の定義

眼科は、眼の疾患や障害の診断、治療、予防に重点を置いた医学および外科の一分野です。白内障、緑内障、黄斑変性、糖尿病網膜症など、眼や視覚系に影響を与える疾患に対する医学的および外科的治療が含まれます。

アジア太平洋地域の眼科市場の定義と動向

ドライバー  

  • 眼疾患の罹患率の増加

白内障、黄斑変性、糖尿病網膜症といった眼疾患の増加は、アジア太平洋地域の眼科市場を大きく牽引する要因となっています。アジア太平洋地域の人口高齢化に伴い、これらの疾患の発症率も上昇しています。白内障は視力低下や失明につながるため、手術や矯正治療の市場規模は拡大しています。同様に、黄斑変性と糖尿病網膜症は、高度な診断ツールと専門的な治療法の必要性を高めています。患者数の増加は、手術、投薬、革新的な診断技術を含む眼科サービスへの継続的な需要を確実なものにしています。こうした眼疾患の急増は市場拡大の直接的な原動力となっており、医療提供者とメーカーは効果的な治療法とソリューションへの高まる需要に応えようと努力しています。

例えば、

  • In July 2022, according to the article published by NCBI, The prevalence of blindness rises with age, increasing from 0.45% in those aged 50-59 to 11.62% in individuals 80 and older. Females (2.31%) and rural residents (2.14%) experience higher rates. Visual impairment also affects 26.68% of participants, showing similar trends. This growing burden of eye diseases, particularly among the elderly, drives demand for ophthalmic treatments and technologies, boosting the ophthalmology market
  • In August 2023, according to the article published by WHO, Asia-Pacific, over 2.2 billion people suffer from vision impairment, with nearly 1 billion cases being preventable or untreated. This growing prevalence of vision issues highlights the increasing demand for eye care services, treatments, and corrective solutions. As more people seek medical attention for preventable or unresolved conditions, the rising burden of eye diseases acts as a significant driver for the ophthalmology market

The rising prevalence of age-related eye conditions like cataracts, macular degeneration, and diabetic retinopathy is fueling the Asia-Pacific ophthalmology market. As the population ages, these diseases become more common, increasing the demand for treatments, surgeries, and diagnostic tools. The need for advanced technologies and therapies grows as more people require care. This surge in eye conditions drives market growth, as healthcare providers and manufacturers aim to meet the rising demand for effective solutions.

  • Focus on Preventative Eye Care  

There is a growing emphasis on preventative eye care and early detection of vision-related issues, which is playing a significant role in driving the Asia-Pacific ophthalmology market. As awareness about the importance of eye health increases, more people are seeking routine eye checkups to detect conditions like glaucoma, diabetic retinopathy, and cataracts in their early stages. Early diagnosis allows for timely interventions, reducing the risk of vision loss and improving overall eye health. This proactive approach is not only improving patient outcomes but also fueling demand for ophthalmic services, diagnostic tools, and corrective treatments. The growing focus on preventative care is leading to a surge in investments in eye care technologies, ophthalmic devices, and services, thereby contributing to the market's expansion. This trend strongly acts as a driver for growth in the ophthalmology sector.

For instance,

  • In October 2022, according to the article published by National Eye Institute, National Eye Health Education Program(NEHEP) collaborates with health professionals to promote awareness on early detection, treatment of eye diseases, and the benefits of vision rehabilitation. It also targets populations at high risk of eye disease and vision loss. This focus on preventative care encourages people to seek timely eye checkups and treatments, driving demand for ophthalmic services, diagnostic tools, and products, thereby fueling the ophthalmology market
  • In October 2024, according to the article published by Directorate General of Health Services, The National Programme for Control of Blindness and Visual Impairment (NPCB&VI) aims to reduce blindness prevalence by identifying and treating curable blindness at all healthcare levels. By focusing on early detection and addressing avoidable blindness, the program highlights the importance of preventative care. This initiative drives demand for eye care services, diagnostic tools, and treatments, contributing significantly to the growth of the Asia-Pacific ophthalmology market

The increasing focus on preventative eye care and early detection is significantly driving the Asia-Pacific ophthalmology market. As awareness of eye health rises, more individuals are opting for routine eye exams to identify conditions like glaucoma and cataracts early. Early detection allows for effective treatments that prevent further vision loss. This proactive approach is driving demand for diagnostic tools, ophthalmic services, and corrective treatments. The growing importance of preventative care is prompting investment in advanced eye care technologies, thus contributing to the overall growth of the ophthalmology market and ensuring its continued expansion.

Opportunities

  • Rise in the Aging Population

The rise in the aging population presents a significant opportunity for the Asia-Pacific ophthalmology market, as older individuals are more susceptible to various eye disorders and diseases. Conditions such as cataracts, age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma are prevalent among the elderly, creating a substantial demand for ophthalmic care and treatments. As a result, healthcare systems and ophthalmic providers are poised to expand their services, enhance diagnostic and therapeutic options, and cater to the unique needs of this demographic. This growing patient base necessitates an array of solutions, from surgical interventions and advanced drug therapies to vision correction products, ensuring a steady and increasing demand for ophthalmic procedures and products.

For instance,

  • In March 2023, according to an article published in the National Library of Medicine, Cataract is a leading cause of visual impairment in old age. Lens opacification is notoriously associated with several geriatric conditions, including frailty, fall risk, depression and cognitive impairment. Moreover, according to the same source, in 2020, the leading worldwide causes of blindness in patients aged 50 years and older were cataract, followed by glaucoma, under-corrected refractive error, age-related macular degeneration, and diabetic retinopathy
  • In August 2022, according to an article published in the American Academy of Ophthalmology, AMD is a common eye disease, usually found in adults over the age of 50. Moreover, it is stated that Half of Americans over the age of 75 develop cataracts

Moreover, addressing the eye health needs of the aging population can stimulate further investments in research and development within the ophthalmology sector. Pharmaceutical companies and medical device manufacturers are focus on creating innovative solutions tailored specifically for age-related conditions, potentially leading to breakthroughs in treatment protocols and patient care. The integration of new technologies, such as tele ophthalmology and advanced imaging techniques, facilitate better management of eye health in older adults, making it easier to monitor and treat conditions remotely. Overall, the aging population amplifies the need for existing ophthalmic services and presents a fertile ground for innovation and growth within the Asia-Pacific ophthalmology market.

  • Rise in Online Retail and E-Health Platforms

The rise of online retail and e-health platforms offers a significant opportunity for the Asia-Pacific ophthalmology market by providing consumers with easier access to a wide array of eye care products and services. With the increasing adoption of e-commerce, patients can conveniently purchase items such as prescription glasses, contact lenses, and over-the-counter eye care products from the comfort of their homes. This trend is especially appealing to younger, tech-savvy consumers and those in remote areas with limited access to traditional optical stores. The ability to compare prices, read reviews, and access a wider range of products online enhances customer satisfaction and encourages usage, thereby driving growth in the ophthalmic product segment.

For instance,

  • In September 2023, according to a news article from The Times of India, the 'pink eye' outbreak led to a surge in sales of ophthalmology medicine. Sales jumped nearly 30% year-on-year for the second month in a row in August - outgrowing the overall market by almost five times. The rise reflects the massive incidence of conjunctivitis and eye-complications in the last few months across the country
  • 2020年4月、「眼鏡のオンライン購入に関する患者の意見」という記事によると、コンタクトレンズのオンライン購入が増加しており、オーストラリア、米国、英国のコンタクトレンズ装用者の10～20％がインターネットでの購入の可能性を検討または調査したことがある。

eヘルスプラットフォームは、小売業の機会に加え、患者が遠隔地から眼科専門医に相談できる遠隔医療サービスを促進します。定期的な眼科検診、フォローアップ、重篤な疾患のトリアージのためのバーチャルコンサルテーションは、特に高齢者や移動に困難を抱える患者にとって、医療へのアクセスを大幅に向上させることができます。これらのプラットフォームは、患者のエンゲージメントと眼科医療に関する推奨事項の遵守を促進し、眼科医が地理的な制約を受けることなく、より幅広い患者層にリーチすることを可能にします。さらに、眼科の健康状態をモニタリングしたり慢性疾患を管理したりするためのモバイルアプリなどのデジタルヘルスツールを統合することで、シームレスな患者体験を提供し、積極的な眼科ケアを促進し、眼科市場の成長をさらに促進することができます。

制約/課題

  • 眼科手術に伴う副作用と合併症

眼科治療は大きく進歩しましたが、特定の眼科処置、特に外科的介入には、感染、瘢痕形成、視力障害といった副作用や合併症のリスクが伴います。これらの潜在的なリスクは、患者が特定の治療、特に侵襲的な処置を伴う治療を躊躇させる要因となります。視力低下や回復期間の長期化といった有害な結果への恐怖は、治療を躊躇させる原因となり、特定の治療法の全体的な導入を阻害する可能性があります。さらに、手術に伴う合併症により追加治療が必要となる場合があり、医療費のさらなる上昇や、先進治療に対する患者の信頼の低下につながります。副作用の可能性を懸念した治療への抵抗感は、新技術や治療法の導入を遅らせ、眼科市場全体の成長を阻害する要因となっています。 

例えば、

  • ハーバード・ヘルスが2024年10月に発表した記事によると、現代の眼科手術は白内障や緑内障などの症状の治療に効果的である一方で、灼熱感、ざらつき、かゆみを伴うドライアイなどの合併症を引き起こすことが多い。この副作用は患者にとって不快感や不安感をもたらし、眼科手術をためらったり避けたりする原因となっている。結果として、治療に伴う合併症は眼科市場の成長を阻害する要因となっている。
  • 2021年7月、Medical News Todayに掲載された記事によると、レーザー眼科手術を受けた人の最大95%がドライアイを経験し、20%がグレアやハローなどの視覚障害を報告しています。さらに、50人に1人がかすみ目や「サハラの砂」症候群に悩まされる可能性があります。これらの副作用は、患者が手術を選択することを躊躇させ、レーザー手術の導入を制限し、眼科市場の成長を阻害する可能性があります。

眼科医療は進歩を遂げていますが、一部の外科治療には感染症、瘢痕、視力障害などのリスクが伴います。これらの合併症は、患者が特定の治療法、特に侵襲的な治療法を選択することを躊躇させる要因となっています。副作用や追加治療費への不安は、患者の治療意欲を低下させ、新しい治療法の導入を遅らせる可能性があります。こうした患者心理が、アジア太平洋地域の眼科市場の成長を阻害しています。

  • 地方における専門的な眼科医療へのアクセスの制限

医療インフラの進歩にもかかわらず、農村部や遠隔地では専門的な眼科医療へのアクセスが依然として限られており、これらの地域における眼科市場の成長ポテンシャルを大きく阻害しています。多くの農村部では、訓練を受けた眼科専門家の不足、設備の不足、高度な診断・治療技術へのアクセスの制限といった課題が依然として存在します。その結果、これらの地域の人々は、眼疾患の適切な診断と治療を受けるのに苦労することが多く、予防可能な失明や視力障害の発生率が高まっています。専門的なケアへのアクセスが限られているため、高度な眼科ケアサービスや製品の導入が減り、市場拡大が制限されています。こうしたアクセス障壁は、アジア太平洋地域の眼科市場全体の成長を阻害する大きな要因となっています。

例えば、

  • 2023年2月、NCBIが発表した論文によると、インドの農村人口は膨大で、満たされていない眼科医療ニーズが深刻であり、医療施設や専門家の大半は都市部および準都市部に集中しています。農村部と都市部における眼科医療へのアクセス格差は依然として課題であり、治療へのアクセスを制限しています。この医療資源の不平等な配分は、農村部における必須サービスへの広範なアクセスを阻害し、アジア太平洋地域の眼科市場の成長を阻害しています。
  • 2024年3月、リサーチゲートが発表した記事によると、「遠隔地では、インターネット接続や訓練を受けたスタッフが不足しているため、眼科キャンプが成功した後でも、継続的な眼科ケアへのアクセスが妨げられています。これらの地域の患者は、適切なインフラが整備されていないため、フォローアップケアや高度な治療を受けるのに苦労しています。この医療提供のギャップは、眼科ケアプログラムの範囲と効果を制限し、アジア太平洋地域の眼科市場の成長を阻害しています。」

医療の質の向上にもかかわらず、地方では専門的な眼科医療へのアクセスが依然として限られています。眼科医療従事者、高度な技術、そして設備の不足により、適切な治療と診断が受けられず、回避可能な失明率の上昇につながっています。こうしたアクセスの制限は、これらの地域における高度な治療とサービスの導入を制限し、アジア太平洋地域の眼科市場の成長を阻害しています。

アジア太平洋地域の眼科市場の範囲

市場は、製品、疾患、総合眼科検査、エンドユーザー、流通チャネルに基づいてセグメント化されています。これらのセグメント間の成長は、業界における成長の少ないセグメントの分析に役立ち、ユーザーに貴重な市場概要と市場洞察を提供し、コア市場アプリケーションを特定するための戦略的意思決定を支援します。

製品別

  • デバイス
    • 外科用デバイス
      • 白内障手術器具
      • 眼科用粘弾性デバイス
        • 超音波乳化吸引装置
        • 白内障手術用レーザー
        • IOLインジェクター
      • 硝子体網膜手術デバイス
        • 硝子体切除術装置
        • 硝子体網膜パック
        • 光凝固レーザー
        • 硝子体切除プローブ
        • 照明装置
      • 屈折矯正手術機器
        • フェムト秒レーザー
        • エキシマレーザー
        • その他の屈折手術用レーザー
      • 緑内障手術機器
        • 緑内障ドレナージ装置
        • 微小侵襲緑内障手術デバイス
        • 緑内障レーザーシステム
    • 診断装置
      • 光干渉断層撮影（OCT）スキャナ
      • オートレフラクトメーターと角膜計
      • 眼圧計
      • フォロプター
      • 網膜鏡
      • 検眼鏡
      • スリットランプ
      • 視野計/視野分析装置
      • 角膜トポグラフィーシステム
      • 眼底カメラ
      • 眼科用超音波画像システム
        • Aスキャンイメージングシステム
        • Bスキャンイメージングシステム
        • パキメーター
        • 超音波生体顕微鏡
      • レンズメーター
      • 波面収差計
      • 光学生体測定システム
      • スペキュラー顕微鏡
      • チャートプロジェクター
    • 眼科手術用アクセサリー
      • 手術器具とキット
      • 眼科用鉗子
      • 眼科用スパチュラ
      • 眼科用チップとハンドル
      • 眼科用カニューラ
      • 眼科用はさみ
      • その他外科用アクセサリー
    • 眼科用顕微鏡
  • 医薬品、副産物
    • 抗VEGF薬
      • ラニビズマブ
      • ベバシズマブ
    • 網膜疾患治療薬
    • 緑内障治療薬
      • プロスタグランジン類似体
        • ラタノプロスト
        • ビマトプロスト
        • トラボプロスト
        • タフルプロスト
        • ラタノプロステン
      • βアドレナリン拮抗薬
        • チモラールマレイン酸塩
        • ベタキソロール
      • アルファアドレナリン作動薬
        • エピネフリン
        • デピベプリン
      • 縮瞳薬
        • ピロカルピン
        • 彼の作品に
    • ドライアイ薬
    • 抗炎症薬
      • ステロイド系抗炎症薬
      • 非ステロイド性抗炎症薬
    • アレルギー性結膜炎の薬
    • その他
  • 薬物、薬物の種類別
    • ブランド
    • ジェネリック
  • 処方モード別医薬品
    • 処方箋
    • 店頭
  • 投与経路別薬剤
    • トピック
      • 目薬
      • アイソリューション
      • クリームと軟膏
      • ゲル
      • その他
    • 地元の眼科
      • 硝子体内
      • 結膜下
      • 球後部
      • 前房内
    • 注射剤
      • 筋肉内
      • 静脈内
      • その他
    • オーラル
      • 錠剤
      • カプセル
      • その他
    • その他
  • その他
    • 視力ケア製品
      • 眼鏡
      • コンタクトレンズ
        • ソフトコンタクトレンズ
        • ハイブリッドコンタクトレンズ
        • 硬質ガス透過性レンズ
    • その他

病気別

  • 白内障
  • 屈折異常
  • 緑内障
  • 加齢黄斑変性症
  • 炎症性疾患
  • その他

By Comprehensive Eye Examination

  • Refraction
    • Automated Refractometers
    • Set of Trial Lenses
    • Cycloplegic Drugs
    • Trial Frame
    • Self-Illuminated/ Mirror Retinoscope
    • Jackson Cross Cylinder
  • Visual Acuity Test
    • Snellen's Chart
    • Near Vision Charts
  • Intraocular Pressure
    • Tonometers (Goldmann, Tono-Pen, Perkins, Shiotz)
    • Others
  • Anterior Segment and Pupillary Examination
    • Slit Lamp Biomicroscope
    • Torch Light
  • Visual Fields Test
    • Central 30-2 Full Threshold Humphrey Visual Field Analyzer
    • Frequency Doubling Perimeter
    • Goldmann Kinetic Perimeter
  • Color Vision Test
  • Others

By End User

  • Clinics
  • Hospitals
  • Home Healthcare
  • Others

By Distribution Channel

  • Retail sales
    • Retail Shops
    • Hospital Pharmacy
    • Online Pharmacy
  • Direct Tender
  • Others

Asia-Pacific Ophthalmology Market Regional Analysis

The market is segmented on the basis of products, diseases, comprehensive eye examination, end user, and distribution channel.

The countries covered in the market are China, India, Japan, South Korea, Australia, Indonesia, Thailand, Malaysia, Philippines, Singapore, and rest of Asia-Pacific.

China is expected to be dominate & fastest growing in the market due to advanced healthcare infrastructure, high healthcare spending, and a large aging population with a growing prevalence of eye diseases. Additionally, significant investments in research, development, and the adoption of cutting-edge technologies drive market leadership in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Asia-Pacific Ophthalmology Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Asia-Pacific Ophthalmology Market Leaders Operating in the Market Are:

  • Alcon (Switzerland)
  • Bausch + Lomb (Canada)
  • Carl Zeiss Meditec( Germany)
  • Hoya Corporation (Japan)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Essilor International (France)
  • Topcon Corporation(Japan)
  • Glaukos Corporation (U.S.)
  • Haag-Streit Group (Switzerland)
  • Nidek Co., Ltd (U.S.)
  • Staar Surgical (California)
  • Ziemer Ophthalmic Systems Ag (Switzerland)
  • Cooper Companies (U.S.)

Latest Developments in Asia-Pacific Ophthalmology Market

  • In October 2024, At the AAO 2024 meeting, Alcon showcased its innovations, including the Voyager DSLT for glaucoma treatment, UNIFEYE and UNIPEXY handheld gas delivery systems, and pivotal data for AR-15512, a dry eye treatment. These advancements aimed to improve outcomes and surgical efficiency
  • In September 2024, EssilorLuxottica and Meta have extended their partnership, entering a long-term agreement to develop multi-generational smart eyewear products. Building on the success of Ray-Ban Meta glasses, the companies aim to shape the future of wearable technology together
  • In OCTOBER 2024, Bausch + Lomb presented new scientific data and educational events at the 2024 AAO meeting in Chicago. Highlights included studies on the enVista Envy IOL, TENEO Excimer Laser, VYZULTA, and presentations on Blink Nutritears, MIEBO, and Xiidra
  • In April 2024, AbbVie has completed its acquisition of Cerevel Therapeutics, enhancing its neuroscience portfolio. The acquisition includes Cerevel’s promising clinical-stage assets like Emraclidine for schizophrenia and Tavapadon for Parkinson's disease, strengthening AbbVie’s position in neurology and psychiatry
  • In September, 2023, Novartis completed the divestment of its 'front of eye' ophthalmology assets to Bausch + Lomb for up to USD 2.5 billion, including USD 1.75 billion in upfront cash and potential milestone payments. The deal included Xiidra®, SAF312, AcuStream, and OJL332. Novartis advanced its strategy to focus on prioritized therapeutic areas for future growth

SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

Sample Image 画像をクリックすると拡大します
  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE ASIA-PACIFIC OPHTHALMOLOGY MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 PRODUCT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

5 ASIA-PACIFIC OPHTHALMOLOGY MARKET : REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING PREVALENCE OF EYE DISEASES

6.1.2 FOCUS ON PREVENTATIVE EYE CARE

6.1.3 GOVERNMENT EYECARE INITIATIVES

6.1.4 INNOVATIONS IN OPHTHALMIC SURGICAL TECHNIQUES

6.2 RESTRAINTS

6.2.1 SIDE EFFECTS AND COMPLICATIONS RELATED TO EYE SURGERIES

6.2.2 LIMITED ACCESS TO SPECIALIZED OPHTHALMIC CARE IN RURAL AREAS

6.3 OPPORTUNITIES

6.3.1 RISE IN THE AGING POPULATION

6.3.2 RISE IN ONLINE RETAIL AND E-HEALTH PLATFORMS

6.3.3 ENHANCED PATIENT EDUCATION

6.4 CHALLENGES

6.4.1 RISING COSTS OF OPHTHALMIC TREATMENTS

6.4.2 SHORTAGE OF EYE CARE PROFESSIONALS

7 ASIA-PACIFIC OPHTHALMOLOGY MARKETASIA-PACIFIC OPHTHALMOLOGY MARKET, BY PRODUCTS

7.1 OVERVIEW

7.2 DEVICE

7.2.1 SURGICAL DEVICE

7.2.1.1 CATARACT SURGICAL DEVICES

7.2.1.2 OPHTHALMIC VISCOELASTIC DEVICES

7.2.1.2.1 PHACOEMULSIFICATION DEVICES

7.2.1.2.2 CATARACT SURGICAL LASERS

7.2.1.2.3 IOL INJECTORS

7.2.1.3 VITREORETINAL SURGICAL DEVICES

7.2.1.3.1 VITREORETINAL PACKS

7.2.1.3.2 VITRECTOMY MACHINES

7.2.1.3.3 VITRECTOMY PROBES

7.2.1.3.4 PHOTOCOAGULATION LASERS

7.2.1.3.5 ILLUMINATION DEVICES

7.2.1.4 REFRACTIVE SURGICAL DEVICES

7.2.1.4.1 FEMTOSECOND LASERS

7.2.1.4.2 EXCIMER LASERS

7.2.1.4.3 OTHER REFRACTIVE SURGICAL LASERS

7.2.1.5 GLAUCOMA SURGICAL DEVICES

7.2.1.5.1 GLAUCOMA DRAINAGE DEVICES

7.2.1.5.2 GLAUCOMA LASER SYSTEMS

7.2.1.5.3 MICRO INVASIVE GLAUCOMA SURGERY DEVICES

7.2.2 DIAGNOSTIC DEVICE

7.2.2.1 OPTICAL COHERENCE TOMOGRAPHY (OCT) SCANNERS

7.2.2.2 AUTOREFRACTORS & KERATOMETERS

7.2.2.3 TONOMETERS

7.2.2.4 PHOROPTERS

7.2.2.5 RETINOSCOPES

7.2.2.6 OPHTHALMOSCOPES

7.2.2.7 SLIT LAMPS

7.2.2.8 PERIMETERS/VISUAL FIELD ANALYZERS

7.2.2.9 CORNEAL TOPOGRAPHY SYSTEMS

7.2.2.10 FUNDUS CAMERAS

7.2.2.11 OPHTHALMIC ULTRASOUND IMAGING SYSTEMS

7.2.2.11.1 A- SCAN IMAGING SYSTEM

7.2.2.11.2 B-SCAN IMAGING SYSTEM

7.2.2.11.3 PACHYMETERS

7.2.2.11.4 ULTRASOUND BIOMICROSCOPES

7.2.2.12 LENSMETERS

7.2.2.13 WAVEFRONT ABERROMETERS

7.2.2.14 OPTICAL BIOMETRY SYSTEMS

7.2.2.15 SPECULAR MICROSCOPES

7.2.2.16 CHART PROJECTORS

7.2.3 OPHTHALMIC SURGICAL ACCESSORIES

7.2.3.1 SURGICAL INSTRUMENTS & KITS

7.2.3.2 OPHTHALMIC FORCEPS

7.2.3.3 OPHTHALMIC SPATULA

7.2.3.4 OPHTHALMIC TIPS AND HANDLES

7.2.3.5 OPHTHALMIC CANNULAS

7.2.3.6 OPHTHALMIC SCISSORS

7.2.3.7 OTHERS SURGICAL ACCESSORIES

7.2.4 OPHTHALMIC MICROSCOPES

7.3 DRUGS

7.3.1 ANTI-VEGF DRUGS

7.3.1.1 RANIBIZUMAB

7.3.1.2 BEVACIZUMAB

7.3.2 ANTI-GLAUCOMA DRUGS

7.3.2.1 PROSTAGLANDIN ANALOGS

7.3.2.1.1 LATANOPROST

7.3.2.1.2 BIMATOPROST

7.3.2.1.3 TRAVOPROST

7.3.2.1.4 TAFLUPROST

7.3.2.1.5 LATANOPROSTENE

7.3.2.2 BETA ADRENERGIC ANTAGONISTS

7.3.2.2.1 TIMOLAL MALEATE

7.3.2.2.2 BETAXOLOL

7.3.2.3 ALPHA ADRENERGIC AGONISTS

7.3.2.3.1 EPINEPHRINE

7.3.2.3.2 DEPIVEPRINE

7.3.2.4 MIOTICS

7.3.2.4.1 PILOCARPINE

7.3.2.4.2 ESERINE

7.3.3 ANTI-INFLAMMATION DRUGS

7.3.3.1 STEROIDAL ANTI-INFLAMMATORY DRUGS

7.3.3.2 NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

7.3.4 RETINAL DISORDER DRUGS

7.3.5 DRY EYE DRUGS

7.3.6 ALLERGIC CONJUCTIVITIS DRUGS

7.3.7 OTHERS

7.3.7.1 BRANDED

7.3.7.2 GENERIC

7.3.7.3 PRESCRIPTION

7.3.7.4 OVER THE COUNTER

7.3.7.5 TOPICAL

7.3.7.6 LOCAL OCULAR

7.3.7.7 INJECTABLES

7.3.7.8 ORAL

7.3.7.9 OTHERS

7.3.7.10 EYE DROPS

7.3.7.11 EYE SOLUTION

7.3.7.12 CREAM & OINTMENTS

7.3.7.13 GEL

7.3.7.14 OTHERS

7.3.7.15 INTRAVITREAL

7.3.7.16 SUBCONJUNCTIVAL

7.3.7.17 RETROBULBAR

7.3.7.18 INTRACAMERAL

7.3.7.19 INTRAMUSCULAR

7.3.7.20 INTRAVENOUS

7.3.7.21 OTHERS

7.3.7.22 TABLET

7.3.7.23 CAPSULES

7.3.7.24 OTHERS

7.4 OTHERS

7.4.1 VISION CARE PRODUCTS

7.4.1.1 SPECTACLES

7.4.1.2 CONTACT LENSES

7.4.1.2.1 SOFT CONTACT LENSES

7.4.1.2.2 HYBRID CONTACT LENSES

7.4.1.2.3 RIGID GAS PERMEABLE LENSES

7.4.2 OTHERS

8 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY DISEASES

8.1 OVERVIEW

8.2 CATARACT

8.3 REFRACTIVE DISORDERS

8.4 GLAUCOMA

8.5 AGE-RELATED MACULAR DEGENERATION

8.6 INFLAMMATORY DISEASES

8.7 OTHERS

9 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION

9.1 OVERVIEW

9.2 REFRACTION

9.2.1 AUTOMATED REFRACTOMETERS

9.2.2 SET OF TRIAL LENSES

9.2.3 CYCLOPLEGIC DRUGS

9.2.4 TRIAL FRAME

9.2.5 SELF-ILLUMINATED/ MIRROR RETINOSCOPE

9.2.6 JACKSON CROSS CYLINDER

9.3 VISUAL ACUITY TEST

9.3.1 SNELLEN'S CHART

9.3.2 NEAR VISION CHARTS

9.4 INTRAOCULAR PRESSURE

9.4.1 TONOMETERS (GOLDMANN, TONO-PEN, PERKINS, SHIOTZ)

9.4.2 OTHERS

9.5 ANTERIOR SEGMENT AND PUPILLARY EXAMINATION

9.5.1 SLIT LAMP BIOMICROSCOPE

9.5.2 TORCH LIGHT

9.6 VISUAL FIELDS TEST

9.6.1 CENTRAL 30-2 FULL THRESHOLD HUMPHREY VISUAL FIELD ANALYZER

9.6.2 FREQUENCY DOUBLING PERIMETER

9.6.3 GOLDMANN KINETIC PERIMETER

9.7 COLOR VISION TEST

9.8 OTHERS

10 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY END USER

10.1 OVERVIEW

10.2 CLINICS

10.3 HOSPITALS

10.4 HOME HEALTHCARE

10.5 OTHERS

11 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL

11.1 OVERVIEW

11.2 RETAIL SALES

11.2.1 RETAIL SHOPS

11.2.2 HOSPITAL PHARMACY

11.2.3 ONLINE PHARMACY

11.3 DIRECT TENDER

11.4 OTHERS

12 ASIA-PACIFIC OPHTHALMOLOGY MARKET BY GEOGRAPHY

12.1 ASIA-PACIFIC

12.1.1 CHINA

12.1.2 INDIA

12.1.3 JAPAN

12.1.4 SOUTH KOREA

12.1.5 AUSTRALIA

12.1.6 INDONESIA

12.1.7 THAILAND

12.1.8 MALAYSIA

12.1.9 PHILIPPINES

12.1.10 SINGAPORE

12.1.11 REST OF ASIA-PACIFIC

13 ASIA-PACIFIC OPHTHALMOLOGY MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

14 SWOT ANALYSIS

15 COMPANY PROFILES

15.1 ALCON

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENT

15.2 JOHNSON & JOHNSON SERVICES, INC.

15.2.1 COMPANY SNAPSHOT

15.2.2 REVENUE ANALYSIS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENT

15.3 ESSILOR LUXOTTICA

15.3.1 COMPANY SNAPSHOT

15.3.2 REVENUE ANALYSIS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT DEVELOPMENT

15.4 NOVARTIS AG

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENT

15.5 BAUSCH + LOMB

15.5.1 COMPANY SNAPSHOT

15.5.2 COMPANY SHARE ANALYSIS

15.5.3 REVENUE ANALYSIS

15.5.4 PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENT

15.6 ABBVIE INC.

15.6.1 COMPANY SNAPSHOT

15.6.2 REVENUE ANALYSIS

15.6.3 PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENT

15.7 BAYER AG

15.7.1 COMPANY SNAPSHOT

15.7.2 REVENUE ANALYSIS

15.7.3 PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENT

15.8 CARL ZEISS MEDITEC AG

15.8.1 COMPANY SNAPSHOT

15.8.2 REVENUE ANALYSIS

15.8.3 PRODUCT PORTFOLIO

15.8.4 RECENT DEVELOPMENT

15.9 COOPER COMPANIES

15.9.1 COMPANY SNAPSHOT

15.9.2 REVENUE ANALYSIS

15.9.3 PRODUCT PORTFOLIO

15.1 DOMPÉ

15.10.1 COMPANY SNAPSHOT

15.10.2 PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENT

15.11 F. HOFFMANN-LA ROCHE LTD

15.11.1 COMPANY SNAPSHOT

15.11.2 REVENUE ANALYSIS

15.11.3 PRODUCT PORTFOLIO

15.11.4 RECENT DEVELOPMENT

15.12 GLAUKOS CORPORATION

15.12.1 COMPANY SNAPSHOT

15.12.2 REVENUE ANALYSIS

15.12.3 PRODUCT PORTFOLIO

15.12.4 RECENT DEVELOPMENT

15.13 HAAG-STREIT

15.13.1 COMPANY SNAPSHOT

15.13.2 PRODUCT PORTFOLIO

15.13.3 RECENT DEVELOPMENT

15.14 HOYA CORPORATION

15.14.1 COMPANY SNAPSHOT

15.14.2 REVENUE ANALYSIS

15.14.3 PRODUCT PORTFOLIO

15.14.4 RECENT DEVELOPMENT

15.15 LUMENIS BE LTD.

15.15.1 COMPANY SNAPSHOT

15.15.2 PRODUCT PORTFOLIO

15.15.3 RECENT DEVELOPMENT

15.16 NIDEK CO.

15.16.1 COMPANY SNAPSHOT

15.16.2 PRODUCT PORTFOLIO

15.16.3 RECENT DEVELOPMENT

15.17 REICHERT, INC

15.17.1 COMPANY SNAPSHOT

15.17.2 REVENUE ANALYSIS

15.17.3 PRODUCT PORTFOLIO

15.17.4 RECENT DEVELOPMENT

15.18 SANTEN PHARMACEUTICAL CO.

15.18.1 COMPANY SNAPSHOT

15.18.2 REVENUE ANALYSIS

15.18.3 PRODUCT PORTFOLIO

15.18.4 RECENT DEVELOPMENT

15.19 STAAR SURGICAL

15.19.1 COMPANY SNAPSHOT

15.19.2 REVENUE ANALYSIS

15.19.3 PRODUCT PORTFOLIO

15.19.4 RECENT DEVELOPMENT

15.2 TOPCON CORPORATION

15.20.1 COMPANY SNAPSHOT

15.20.2 REVENUE ANALYSIS

15.20.3 PRODUCT PORTFOLIO

15.20.4 RECENT DEVELOPMENT

15.21 ZIEMER OPHTHALMIC SYSTEMS AG

15.21.1 COMPANY SNAPSHOT

15.21.2 PRODUCT PORTFOLIO

15.21.3 RECENT DEVELOPMENT

16 QUESTIONNAIRE

17 RELATED REPORTS

表のリスト

TABLE 1 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 2 ASIA-PACIFIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 3 ASIA-PACIFIC SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 4 ASIA-PACIFIC OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 5 ASIA-PACIFIC VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 6 ASIA-PACIFIC REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 7 ASIA-PACIFIC GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 8 ASIA-PACIFIC DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 9 ASIA-PACIFIC OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 10 ASIA-PACIFIC OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 11 ASIA-PACIFIC DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 12 ASIA-PACIFIC ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 13 ASIA-PACIFIC ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 14 ASIA-PACIFIC PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 15 ASIA-PACIFIC BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 16 ASIA-PACIFIC ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 17 ASIA-PACIFIC MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 18 ASIA-PACIFIC ANTI INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 19 ASIA-PACIFIC DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 20 ASIA-PACIFIC DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 21 ASIA-PACIFIC DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 22 ASIA-PACIFIC TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 23 ASIA-PACIFIC LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 24 ASIA-PACIFIC INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 25 ASIA-PACIFIC ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 26 ASIA-PACIFIC OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 27 ASIA-PACIFIC VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 28 ASIA-PACIFIC CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 29 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 30 ASIA-PACIFIC CATARACT IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 31 ASIA-PACIFIC REFRACTIVE DISORDERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 32 ASIA-PACIFIC GLAUCOMA IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 33 ASIA-PACIFIC AGE-RELATED MACULAR DEGENERATION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 34 ASIA-PACIFIC INFLAMMATORY DISEASES IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 35 ASIA-PACIFIC OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 36 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 37 ASIA-PACIFIC REFRACTION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 38 ASIA-PACIFIC REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 39 ASIA-PACIFIC VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 40 ASIA-PACIFIC VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 41 ASIA-PACIFIC INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 42 ASIA-PACIFIC INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 43 ASIA-PACIFIC ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 44 ASIA-PACIFIC ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 45 ASIA-PACIFIC VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 46 ASIA-PACIFIC VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 47 ASIA-PACIFIC COLOR VISION TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 48 ASIA-PACIFIC OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 49 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 50 ASIA-PACIFIC CLINICS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 51 ASIA-PACIFIC HOSPITALS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 52 ASIA-PACIFIC HOME HEALTHCARE IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 53 ASIA-PACIFIC OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 54 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 55 ASIA-PACIFIC RETAIL SALES IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 56 ASIA-PACIFIC RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 57 ASIA-PACIFIC DIRECT TENDER IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 58 ASIA-PACIFIC OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 59 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY COUNTRY, 2018-2032 (USD MILLION)

TABLE 60 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 61 ASIA-PACIFIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 62 ASIA-PACIFIC SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 63 ASIA-PACIFIC OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 64 ASIA-PACIFIC VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 65 ASIA-PACIFIC REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 66 ASIA-PACIFIC GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 67 ASIA-PACIFIC DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 68 ASIA-PACIFIC OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 69 ASIA-PACIFIC OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 70 ASIA-PACIFIC DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 71 ASIA-PACIFIC ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 72 ASIA-PACIFIC ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 73 ASIA-PACIFIC PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 74 ASIA-PACIFIC BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 75 ASIA-PACIFIC ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 76 ASIA-PACIFIC MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 77 ASIA-PACIFIC ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 78 ASIA-PACIFIC OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 79 ASIA-PACIFIC VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 80 ASIA-PACIFIC CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 81 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 82 ASIA-PACIFIC DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 83 ASIA-PACIFIC DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 84 ASIA-PACIFIC DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 85 ASIA-PACIFIC TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 86 ASIA-PACIFIC LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 87 ASIA-PACIFIC INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 88 ASIA-PACIFIC ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 89 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 90 ASIA-PACIFIC REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 91 ASIA-PACIFIC VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 92 ASIA-PACIFIC INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 93 ASIA-PACIFIC ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 94 ASIA-PACIFIC VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 95 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 96 ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 97 ASIA-PACIFIC RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 98 CHINA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 99 CHINA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 100 CHINA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 101 CHINA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 102 CHINA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 103 CHINA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 104 CHINA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 105 CHINA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 106 CHINA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 107 CHINA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 108 CHINA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 109 CHINA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 110 CHINA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 111 CHINA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 112 CHINA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 113 CHINA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 114 CHINA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 115 CHINA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 116 CHINA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 117 CHINA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 118 CHINA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 119 CHINA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 120 CHINA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 121 CHINA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 122 CHINA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 123 CHINA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 124 CHINA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 125 CHINA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 126 CHINA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 127 CHINA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 128 CHINA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 129 CHINA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 130 CHINA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 131 CHINA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 132 CHINA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 133 CHINA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 134 CHINA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 135 CHINA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 136 INDIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 137 INDIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 138 INDIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 139 INDIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 140 INDIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 141 INDIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 142 INDIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 143 INDIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 144 INDIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 145 INDIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 146 INDIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 147 INDIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 148 INDIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 149 INDIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 150 INDIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 151 INDIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 152 INDIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 153 INDIA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 154 INDIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 155 INDIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 156 INDIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 157 INDIA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 158 INDIA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 159 INDIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 160 INDIA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 161 INDIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 162 INDIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 163 INDIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 164 INDIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 165 INDIA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 166 INDIA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 167 INDIA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 168 INDIA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 169 INDIA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 170 INDIA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 171 INDIA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 172 INDIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 173 INDIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 174 JAPAN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 175 JAPAN DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 176 JAPAN SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 177 JAPAN OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 178 JAPAN VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 179 JAPAN REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 180 JAPAN GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 181 JAPAN DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 182 JAPAN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 183 JAPAN OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 184 JAPAN DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 185 JAPAN ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 186 JAPAN ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 187 JAPAN PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 188 JAPAN BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 189 JAPAN ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 190 JAPAN MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 191 JAPAN ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 192 JAPAN OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 193 JAPAN VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 194 JAPAN CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 195 JAPAN OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 196 JAPAN DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 197 JAPAN DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 198 JAPAN DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 199 JAPAN TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 200 JAPAN LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 201 JAPAN INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 202 JAPAN ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 203 JAPAN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 204 JAPAN REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 205 JAPAN VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 206 JAPAN INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 207 JAPAN ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 208 JAPAN VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 209 JAPAN OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 210 JAPAN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 211 JAPAN RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 212 SOUTH KOREA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 213 SOUTH KOREA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 214 SOUTH KOREA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 215 SOUTH KOREA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 216 SOUTH KOREA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 217 SOUTH KOREA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 218 SOUTH KOREA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 219 SOUTH KOREA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 220 SOUTH KOREA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 221 SOUTH KOREA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 222 SOUTH KOREA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 223 SOUTH KOREA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 224 SOUTH KOREA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 225 SOUTH KOREA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 226 SOUTH KOREA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 227 SOUTH KOREA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 228 SOUTH KOREA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 229 SOUTH KOREA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 230 SOUTH KOREA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 231 SOUTH KOREA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 232 SOUTH KOREA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 233 SOUTH KOREA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 234 SOUTH KOREA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 235 SOUTH KOREA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 236 SOUTH KOREA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 237 SOUTH KOREA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 238 SOUTH KOREA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 239 SOUTH KOREA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 240 SOUTH KOREA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 241 SOUTH KOREA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 242 SOUTH KOREA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 243 SOUTH KOREA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 244 SOUTH KOREA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 245 SOUTH KOREA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 246 SOUTH KOREA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 247 SOUTH KOREA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 248 SOUTH KOREA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 249 SOUTH KOREA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 250 AUSTRALIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 251 AUSTRALIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 252 AUSTRALIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 253 AUSTRALIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 254 AUSTRALIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 255 AUSTRALIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 256 AUSTRALIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 257 AUSTRALIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 258 AUSTRALIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 259 AUSTRALIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 260 AUSTRALIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 261 AUSTRALIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 262 AUSTRALIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 263 AUSTRALIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 264 AUSTRALIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 265 AUSTRALIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 266 AUSTRALIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 267 AUSTRALIA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 268 AUSTRALIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 269 AUSTRALIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 270 AUSTRALIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 271 AUSTRALIA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 272 AUSTRALIA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 273 AUSTRALIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 274 AUSTRALIA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 275 AUSTRALIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 276 AUSTRALIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 277 AUSTRALIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 278 AUSTRALIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 279 AUSTRALIA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 280 AUSTRALIA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 281 AUSTRALIA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 282 AUSTRALIA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 283 AUSTRALIA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 284 AUSTRALIA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 285 AUSTRALIA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 286 AUSTRALIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 287 AUSTRALIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 288 INDONESIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 289 INDONESIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 290 INDONESIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 291 INDONESIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 292 INDONESIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 293 INDONESIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 294 INDONESIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 295 INDONESIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 296 INDONESIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 297 INDONESIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 298 INDONESIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 299 INDONESIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 300 INDONESIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 301 INDONESIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 302 INDONESIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 303 INDONESIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 304 INDONESIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 305 INDONESIA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 306 INDONESIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 307 INDONESIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 308 INDONESIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 309 INDONESIA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 310 INDONESIA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 311 INDONESIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 312 INDONESIA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 313 INDONESIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 314 INDONESIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 315 INDONESIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 316 INDONESIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 317 INDONESIA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 318 INDONESIA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 319 INDONESIA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 320 INDONESIA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 321 INDONESIA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 322 INDONESIA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 323 INDONESIA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 324 INDONESIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 325 INDONESIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 326 THAILAND OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 327 THAILAND DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 328 THAILAND SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 329 THAILAND OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 330 THAILAND VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 331 THAILAND REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 332 THAILAND GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 333 THAILAND DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 334 THAILAND OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 335 THAILAND OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 336 THAILAND DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 337 THAILAND ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 338 THAILAND ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 339 THAILAND PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 340 THAILAND BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 341 THAILAND ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 342 THAILAND MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 343 THAILAND ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 344 THAILAND OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 345 THAILAND VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 346 THAILAND CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 347 THAILAND OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 348 THAILAND DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 349 THAILAND DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 350 THAILAND DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 351 THAILAND TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 352 THAILAND LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 353 THAILAND INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 354 THAILAND ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 355 THAILAND OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 356 THAILAND REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 357 THAILAND VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 358 THAILAND INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 359 THAILAND ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 360 THAILAND VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 361 THAILAND OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 362 THAILAND OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 363 THAILAND RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 364 MALAYSIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 365 MALAYSIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 366 MALAYSIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 367 MALAYSIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 368 MALAYSIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 369 MALAYSIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 370 MALAYSIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 371 MALAYSIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 372 MALAYSIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 373 MALAYSIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 374 MALAYSIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 375 MALAYSIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 376 MALAYSIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 377 MALAYSIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 378 MALAYSIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 379 MALAYSIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 380 MALAYSIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 381 MALAYSIA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 382 MALAYSIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 383 MALAYSIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 384 MALAYSIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 385 MALAYSIA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 386 MALAYSIA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 387 MALAYSIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 388 MALAYSIA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 389 MALAYSIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 390 MALAYSIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 391 MALAYSIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 392 MALAYSIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 393 MALAYSIA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 394 MALAYSIA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 395 MALAYSIA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 396 MALAYSIA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 397 MALAYSIA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 398 MALAYSIA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 399 MALAYSIA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 400 MALAYSIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 401 MALAYSIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 402 PHILIPPINES OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 403 PHILIPPINES DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 404 PHILIPPINES SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 405 PHILIPPINES OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 406 PHILIPPINES VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 407 PHILIPPINES REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 408 PHILIPPINES GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 409 PHILIPPINES DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 410 PHILIPPINES OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 411 PHILIPPINES OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 412 PHILIPPINES DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 413 PHILIPPINES ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 414 PHILIPPINES ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 415 PHILIPPINES PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 416 PHILIPPINES BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 417 PHILIPPINES ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 418 PHILIPPINES MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 419 PHILIPPINES ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 420 PHILIPPINES OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 421 PHILIPPINES VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 422 PHILIPPINES CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 423 PHILIPPINES OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 424 PHILIPPINES DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 425 PHILIPPINES DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 426 PHILIPPINES DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 427 PHILIPPINES TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 428 PHILIPPINES LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 429 PHILIPPINES INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 430 PHILIPPINES ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 431 PHILIPPINES OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 432 PHILIPPINES REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 433 PHILIPPINES VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 434 PHILIPPINES INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 435 PHILIPPINES ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 436 PHILIPPINES VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 437 PHILIPPINES OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 438 PHILIPPINES OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 439 PHILIPPINES RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 440 SINGAPORE OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 441 SINGAPORE DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 442 SINGAPORE SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 443 SINGAPORE OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 444 SINGAPORE VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 445 SINGAPORE REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 446 SINGAPORE GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 447 SINGAPORE DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 448 SINGAPORE OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 449 SINGAPORE OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 450 SINGAPORE DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 451 SINGAPORE ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 452 SINGAPORE ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 453 SINGAPORE PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 454 SINGAPORE BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 455 SINGAPORE ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 456 SINGAPORE MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 457 SINGAPORE ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 458 SINGAPORE OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 459 SINGAPORE VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 460 SINGAPORE CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 461 SINGAPORE OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 462 SINGAPORE DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 463 SINGAPORE DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 464 SINGAPORE DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 465 SINGAPORE TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 466 SINGAPORE LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 467 SINGAPORE INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 468 SINGAPORE ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 469 SINGAPORE OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 470 SINGAPORE REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 471 SINGAPORE VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 472 SINGAPORE INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 473 SINGAPORE ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 474 SINGAPORE VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 475 SINGAPORE OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 476 SINGAPORE OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 477 SINGAPORE RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 478 REST OF ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

図表一覧

FIGURE 1 ASIA-PACIFIC OPHTHALMOLOGY MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC OPHTHALMOLOGY MARKET: DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC OPHTHALMOLOGY MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC OPHTHALMOLOGY MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC OPHTHALMOLOGY MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC OPHTHALMOLOGY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA-PACIFIC OPHTHALMOLOGY MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 ASIA-PACIFIC OPHTHALMOLOGY MARKET: DBMR MARKET POSITION GRID

FIGURE 9 ASIA-PACIFIC OPHTHALMOLOGY MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA-PACIFIC OPHTHALMOLOGY MARKET: SEGMENTATION

FIGURE 11 THREE SEGMENTS COMPRISE THE ASIA-PACIFIC OPHTHALMOLOGY MARKET, BY PRODUCTS

FIGURE 12 EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 RISING INCIDENCE OF EYE DISORDERS IS DRIVING THE GROWTH OF THE ASIA-PACIFIC OPHTHALMOLOGY MARKET FROM 2025 TO 2032

FIGURE 15 THE PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC OPHTHALMOLOGY MARKET IN 2025 AND 2032

FIGURE 16 DROC ANALYSIS

FIGURE 17 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY PRODUCTS, 2024

FIGURE 18 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY PRODUCTS, 2025-2032 (USD MILLION)

FIGURE 19 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY PRODUCTS, CAGR (2025-2032)

FIGURE 20 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY PRODUCTS, LIFELINE CURVE

FIGURE 21 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY DISEASES, 2024

FIGURE 22 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY DISEASES, 2025-2032 (USD MILLION)

FIGURE 23 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY DISEASES, CAGR (2025-2032)

FIGURE 24 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY DISEASES, LIFELINE CURVE

FIGURE 25 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, 2024

FIGURE 26 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, 2025-2032 (USD MILLION)

FIGURE 27 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, CAGR (2025-2032)

FIGURE 28 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, LIFELINE CURVE

FIGURE 29 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY END USER, 2024

FIGURE 30 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY END USER, 2025-2032 (USD MILLION)

FIGURE 31 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY END USER, CAGR (2025-2032)

FIGURE 32 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY END USER, LIFELINE CURVE

FIGURE 33 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL ,2024

FIGURE 34 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)

FIGURE 35 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)

FIGURE 36 ASIA-PACIFIC OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 37 ASIA-PACIFIC OPHTHALMOLOGY MARKET SNAPSHOT

FIGURE 38 ASIA-PACIFIC OPHTHALMOLOGY MARKET: COMPANY SHARE 2024 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

Major companies in the Asia-Pacific ophthalmology market are Alcon, Regeneron Pharmaceuticals Inc., Johnson & Johnson, Inc., Reichert, Inc., Novartis AG, Bausch & Lomb Incorporated, HOYA Corporation., The Cooper Companies Inc., Santen Pharmaceutical Co., Ltd., etc.
Products, disease, prescription mode, drug type, route of administration, end-user, and distribution channel are the factors on which the Asia-Pacific ophthalmology market research is based.
Rising prevalence of ophthalmic disorders, ocular pains & rise in traumatic injuries are the growth drivers of the Asia-Pacific ophthalmology market.

関連ページを閲覧する

Banner
Testimonial
Image
David Manning - Thermo Fisher Scientific Director, Global Strategic Accounts,
Dear Ricky, I want to thank you for the excellent market analysis (LIMS INSTALLED BASE DATA) that you and your team delivered, especially end of year on short notice. Sachin and Shraddha captured the requirements, determined their path forward and executed quickly.
You, Sachin and Shraddha have been a pleasure to work with – very responsive, professional and thorough. Your work is much appreciated.
Image
Manager - Market Analytics, Uriah D. Avila - Zeus Polymer Solutions
Thank you for all the assistance and the level of detail in the market report. We are very pleased with the results and the customization. We would like to continue to do business.
Image
Business Development Manager, (Pharmaceuticals Partner for Nasal Sprays) | Renaissance Lakewood LLC
DBMR was attentive and engaged while discussing the Global Nasal Spray Market. They understood what we were looking for and was able to provide some examples from the report as requested. DBMR Service team has been responsive as needed. Depending on what my colleagues were looking for, I will recommend your services and would be happy to stay connected in case we can utilize your research in the future.
Image
Business Intelligence and Analytics, Ipsen Biopharm Limited

We are impressed by the CENTRAL PRECOCIOUS PUBERTY (CPP) TREATMENT report - so a BIG thanks to you colleagues.

Image
Competition Analyst, Basler Web

I just wanted to share a quick note and let you know that you guys did a really good job. I’m glad I decided to work with you. I shall continue being associated with your company as long as we have market intelligence needs.

Image
Marketing Director, Buhler Group

It was indeed a good experience, would definitely recommend and come back for future prospects.

Image
COO, A global leader providing Drug Delivery Services

DBMR did an outstanding job on the Global Drug Delivery project, We were extremely impressed by the simple but comprehensive presentation of the study and the quality of work done. This report really helped us to access untapped opportunities across the globe.

Image
Marketing Director, Philips Healthcare

The study was customized to our targets and needs with well-defined milestones. We were impressed by the in-depth customization and inclusion of not only major but also minor players across the globe. The DBMR Market position grid helped us to analyze the market in different dimension which was very helpful for the team to get into the minute details.

Image
Product manager, Fujifilms

Thankful to the team for the amazing coordination, and helping me at the last moment with my presentation. It was indeed a comprehensive report that gave us revenue impacting solution enabling us to plan the right move.

Image
Investor relations, GE Healthcare

Thank you for the report, and addressing our needs in such short time. DBMR has outdone themselves in this project with such short timeframe.

Image
Market Analyst, Medincell

We found the results of this study compelling and will help our organization validate a market we are considering to enter. Thank you for a job well done.

Image
Andrew - Senior Global Marketing Manager, Medtronic (US)

I want to thank you for your help with this report – It’s been very helpful in our business planning and it well organized.

Image
Amarildo - Manager, Global Strategic Alignment MasterCard

We believe the work done by Data Bridge Team for our requirements in the North America Loyalty Management Market was fantastic and would love to continue working with your team moving forward.

Image
Tor Hammer Green Nexus LLc

Thank you for your quick response to this unfortunate circumstance. Please extend my thanks to your reach team. I will be contacting you in the future with further projects

Image
Tommaso Finocchiaro Market Intelligence Specialist Nippon Gasses

I acknowledge the difficulty given by the very short warning for this report, and I think that its quality and your delivering time have been very satisfying. Obviously, as a provider Data Bridge Market Research will be considered as a plus for future needs of Nippon Gases.

Image
Yuki Kopyl (Asian Business Development Department) UENO FOOD TECHNO INDUSTRY, LTD. (JAPAN)

Xylose report was very useful for our team. Thank you very much & hope to work with you again in the future